BrainXell
PrivateLast Round
Grant
Aug 8, 2023
Total Funding Raised
$19.66M
Company Overview
BrainXell is a biotechnology company that manufactures customized nervous system cells derived from human stem cell lines for use in research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainXell Comparables
Compare BrainXell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iXCells Biotechnologies | 88% | |
| NeuCyte | 87% | |
| Axol Bioscience | 86% |
BrainXell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 8, 2023 | ||||
| Series B | Sep 28, 2021 | ||||
| Accelerator | Nov 1, 2016 | ||||
| Grant | Sep 1, 2016 |
BrainXell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Wisconsin Economic Development Corporation | Grant |
| WARF Ventures | Series B |
| Discovery to Product | Accelerator |
| California Institute for Regenerative Medicine | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 49% MoM, reaching 4K.
- May 2, 2025
Monthly visitors increased 35% to 2.3K.
Recent news
Latest coverage and updates
- is_developingJun 16, 2026
BrainXell, Inc. is developing New Approach Methodology platforms on Jun 16th '26.
- is_developingJun 16, 2026
BrainXell, Inc. is developing integrated platforms that better capture the complexity of the human central nervous system on Jun 16th '26.
BrainXell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BrainXell's valuation, stock price, and market status.
Is BrainXell a public or private company?
BrainXell is a private company.
What is the current stock price of BrainXell?
BrainXell is a private company with no public stock price. No recent secondary market data is available.
How much is BrainXell worth (valuation)?
Valuation information for BrainXell is not publicly available.
Can I buy BrainXell stock?
BrainXell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BrainXell's last funding round?
BrainXell's most recent funding round was Grant on August 8, 2023.
Who are the main investors in BrainXell?
Key investors in BrainXell include NIH RADx, Wisconsin Economic Development Corporation, WARF Ventures, Discovery to Product, California Institute for Regenerative Medicine.
Will BrainXell IPO soon?
No public IPO plans have been announced for BrainXell.
How can I track BrainXell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BrainXell's secondary market activity and sign up for updates.